Investigating the impact of environmental pollutants on female fertility
Official title: FERTilité féminine, Agents ENvironnementaux et Stress OXydant
Run by University Hospital, Tours · NCT04866329 · Data updated 2026-11-12
This study is trying to see how certain environmental pollutants affect the fertility of women undergoing in vitro fertilization (IVF).
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 43 Years |
| Sex | Women only |
| Enrollment | 500 (estimated) |
| Sponsor | University Hospital, Tours Academic / other |
| Locations | 1 site (Tours) |
| Status | Recruiting |
| Started | December 8, 2021 |
| Main results expected | December 8, 2026 |
| Study ends | December 2027 |
| Registry record updated | July 25, 2024 |
| Trial ID | NCT04866329 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 to 43 who are undergoing their first oocyte retrieval as part of an IVF protocol.
✕Probably not a fit
Patients who have previously undergone IVF procedures or are using egg donation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to analyze the effects of various environmental agents, such as bisphenols, ethynylestradiol, and glyphosate, on female fertility. Women undergoing in vitro fertilization (IVF) at the University Hospital of Tours will be recruited to provide blood, urine, and follicular fluid samples, alongside completing a lifestyle questionnaire. The study will assess the relationship between the levels of these pollutants in the samples and the quality of oocytes, as well as the success rates of IVF and pregnancy outcomes. The research seeks to understand how oxidative stress and endocrine disruptors may influence reproductive health.
Why it matters
Potential benefit: If successful, this study could provide insights into how environmental pollutants affect female fertility, potentially leading to improved IVF outcomes.
How similar studies have gone: While studies have explored the effects of environmental pollutants on fertility, this specific approach focusing on IVF patients and oxidative stress is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Woman aged 18 to 43 years old * First oocyte puncture (IVF rank = 1) Exclusion Criteria: * Opposition to data processing * IVF rank equal or greater than 2 * Egg donation * Intracytoplasmic Sperm Injection with testicular biopsy * Intracytoplasmic Sperm Injection with self-preservation straw * Sperm donation
Where it's running
-
Department of Reproductive Medicine and Biology, Univesity Hospital, Tours
Tours, France Recruiting
Study contacts
- Principal investigator: Fabrice GUERIF, MD-PhD — University Hospital, Tours
- Study coordinator: Fabrice GUERIF, MD-PhD
- Email: fabrice.guerif@univ-tours.fr
- Phone: 02.47.47.84.76
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blocking RANKL with denosumab to protect ovarian follicles
This trial will test whether giving denosumab, a drug that blocks RANKL, can help protect follicle development in women with infertility who are undergoing assisted reproduction.
-
Effect of a 21-day comprehensive spa program on female infertility
This study tests whether a 21-day spa treatment can impact hormonal profiles and reproductive outcomes in women ages 20-40 with infertility.
-
Endometrial immune profile changes after putting your own PRP into the uterus
This test will try whether putting a person's own platelet-rich plasma (PRP) into the uterus improves the uterine immune profile, thickness, hormone levels, and pregnancy rates for people undergoing IVF with euploid embryo transfer.
-
Day-4 embryo defragmentation to improve blastocyst formation and pregnancy outcomes
This study tests whether removing cytoplasmic fragments from Day-4 morula-stage embryos helps people undergoing ICSI get more blastocysts and better pregnancy chances.
-
PPOS versus GnRH antagonist IVF protocols for women with PCOS
This trial will test whether a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol gives better IVF outcomes for women aged 18–40 with PCOS.
-
Adding mitochondria from your own fat stem cells to eggs to try to improve IVF success
This procedure will try adding mitochondria from your own adipose (fat) stem cells into eggs during ICSI to see if embryo quality and pregnancy rates improve for people with multiple prior IVF failures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.